Atrial Fibrillation > Cardiac Surgery

Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Recruiting in Palo Alto (17 mi)

+2 other locations

Overseen By Nassir Marrouche, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Tulane University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize that patients with a higher baseline Utah fibrosis staging will experience a higher incidence of POAF. The study also aims to evaluate and compare the in-hospital mortality, length-of-stay (LOS), complication rates (strokes, pneumonia, respiratory failure etc.) of the different Utah fibrosis stage cohorts. Perform cost analysis and compare between patients with POAF and patients without POAF. The investigators hypothesize that patients experiencing POAF will have a higher mortality rate, longer LOS, greater complications, and therefore, additional hospital costs.

Eligibility Criteria

Participant Groups

Find A Clinic Near You

Research locations nearby Select from list below to view details:

University Medical Center New Orleans New Orleans, LA

Tulane University Medical Center New Orleans, LA

Washington University Barnes-Jewish Hospital Saint Louis, MO

Who is running the clinical trial?

Tulane University Lead Sponsor

References